MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychological assessment in a cohort of patients with Parkinson’s disease

C. Juri, W. Uslar, H. Farias, M. Vasquez (Santiago, Chile)

Meeting: 2016 International Congress

Abstract Number: 1361

Keywords: Cognitive dysfunction

Session Information

Date: Wednesday, June 22, 2016

Session Title: Cognitive disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson’s disease (PD) using a standardised battery.

Background: Cognitive impairment is a great challenge in patients with Parkinson´s Disease (PD). The variation in tools used for cognitive evaluation is an additional problem in this population.We present a neuropsychological assessment in a PD population using a standardized battery based on Movement disorders Society recommendations.

Methods: Consecutive PD patients according to London Barin Bank Criteria were evaluated extensively for different cognitive domains (attention, memory, language, executive functions and processing speed) and depressive symptoms using an stndarized battery. Cognitive impairment was diagnosed according to MDS criteria.

Results: Twenty five patients were included. Age (mean+/-SD) was 60.8±11.7 years, 28% were females. PD evolution was between 2 and 15 years. Alterations in at least one neuropsychological test were present in 100% of subjects. Dementia was diagnosed in 18% of patients, whereas mild cognitive impairment was present in 36% of the cases. Dementia was present in 60% of those older than 70 years. MoCA test was affected in 80% of cases (Z: -2.6±1.9). AVLT (Episodic auditive verbal memory) was altered in 84% of subjects (Z: -3,8±2.0). BVMT (Visuospatial memory) was affected in 44% of patients (Z: -1,4±0.9). Boston test (semantic memory) was altered in 40 subjects (Z:-1.1±1.2). TMT-A (visual attention) was altered in 32% of cases (Z: 0,6±2.4). Digit Span (Auditive attention) was affected in 32% of patients (Z: -0.4±1.8). SDMT (Processing speed) was altered in 24% of cases (Z:-0.4±1.0). FAS (cognitive alternancy) was affected in 28% of subjects (Z:-0.5±1.4). The tower test of D-KEFS was altered in 20%, (Z:-0,5 ± 1.4). Depressive symptoms were found in 53% of patients.

Conclusions: We found a high percentage of cognitive alterations in our PD population. Both verbal and visual episodic memories were affected in 50% of patients. As previously reported, older patients were more affected by dementia. FONDECYT Nº 11130534.

XII World Congress of Neurology.

To cite this abstract in AMA style:

C. Juri, W. Uslar, H. Farias, M. Vasquez. Neuropsychological assessment in a cohort of patients with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/neuropsychological-assessment-in-a-cohort-of-patients-with-parkinsons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychological-assessment-in-a-cohort-of-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley